SARS-CoV-2 Mpro-IN-25

• UNSPSC Description:

  SARS-CoV-2 Mpro-IN-25 (Compound 3a) is a SARS-CoV-2 protease inhibitor with an IC50 value of 0.26 μM. SARS-CoV-2 Mpro-IN-25 exhibits antiviral activity and can be used in pneumonia-related research[1].

• Target Antigen:

  Virus Protease

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-mpro-in-25.html

• Smiles:

  O=C(C1=CC(O)=C(C(O)=C1)O)NC2=CC=C(C=C2)F

• Molecular Weight:

  263.22

• References & Citations:

  [1]de Carvalho MAG, et al. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease. Arch Pharm (Weinheim). 2024 Aug 15:e2400253.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2205006-23-9